In a strategic move to bolster AI security and governance in the life sciences industry, Hexaware Technologies has announced a partnership with Abluva Inc, a leader in data security and agentic AI protection. This collaboration aims to address the urgent need for robust governance frameworks for autonomous AI agents operating in highly regulated and complex healthcare environments.
The partnership integrates Abluva’s Secure Intelligence Plane with Hexaware’s digital transformation expertise to deliver real-time, secure, and scalable AI governance solutions. These will be tailored to the unique needs of life sciences enterprises navigating the intricacies of GenAI adoption.
“We are thrilled to partner with Abluva to implement the most secure agentic AI solutions for large sponsors and CROs,” stated Raj Gondhali, AVP & Head of Clinical Solutions, Hexaware. “This collaboration is pivotal, combining our expertise in global clinical solutions with Abluva’s pioneering agentic security technology to ensure enhanced AI safety, compliance, and operational efficiency as our clients adopt next-generation AI.”
This alliance underscores Hexaware’s commitment to leading-edge cloud and AI platforms while highlighting Abluva’s innovation in agentic security, empowering life sciences firms to securely scale their AI initiatives.
Abluva Inc stands at the forefront of research-driven data security, offering advanced protection for generative AI systems, agents, and data environments. Their solutions enable fine-grained access control, privacy, and breach detection to help clients accelerate innovation securely.
Hexaware Technologies is a global technology and business process services company that helps enterprises scale and optimise their digital transformation initiatives.
Also Read: HCLTech Becomes Workday Sales Partner to Boost AI Powered Workforce Transformation!
As of 11 July 2025, at 3:12 PM, Hexaware Technologies share price is trading at ₹859.50 per share, reflecting a decline of 1.34%.
The Hexaware–Abluva partnership signals a timely and strategic advancement in the governance of AI systems in healthcare and life sciences. With this move, both companies aim to foster greater trust in AI while delivering on security, compliance, and scalability in one of the most sensitive sectors embracing digital transformation.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 11, 2025, 3:48 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates